Candriam Equities L Biotech.I GBP Acc/ LU1269737059 /
| NAV2024-07-25 | Chg.+50.4399 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 3,725.7200GBP | +1.37% | reinvestment | Equity Worldwide | Candriam ▶ |
Monthly performance
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2016 | - | - | - | 1.64 | 6.04 | -0.12 | 13.33 | -1.09 | 4.68 | -6.72 | 6.19 | -1.75 | - |
| 2017 | 3.79 | 8.04 | -0.55 | -2.13 | -2.82 | 8.54 | 1.05 | 8.83 | -3.11 | -5.36 | -1.59 | 1.59 | +16.06% |
| 2018 | 1.61 | -1.63 | -3.64 | -1.30 | 8.37 | 1.78 | 5.19 | 5.17 | -2.34 | -12.18 | 4.36 | -8.08 | -4.56% |
| 2019 | 9.61 | 2.35 | 1.48 | -4.90 | -1.46 | 8.35 | 1.42 | -1.75 | -5.56 | 5.58 | 11.94 | 0.07 | +28.66% |
| 2020 | -4.76 | 2.04 | -2.16 | 10.91 | 11.53 | 1.46 | -8.51 | -1.07 | 4.34 | -2.82 | 6.39 | 0.66 | +17.29% |
| 2021 | 1.42 | -4.25 | -2.92 | 2.44 | -4.49 | 9.25 | -2.01 | 5.05 | -2.18 | -1.72 | -0.76 | -0.59 | -1.63% |
| 2022 | -9.93 | -1.98 | 7.73 | -3.11 | -3.70 | 6.91 | 4.41 | 5.70 | 2.20 | 3.71 | 2.65 | -3.74 | +9.66% |
| 2023 | 0.63 | -4.09 | -1.65 | 0.61 | 0.20 | -1.29 | -1.32 | 1.37 | -0.65 | -5.57 | 1.60 | 12.72 | +1.50% |
| 2024 | 1.44 | 2.04 | 0.19 | -5.29 | 2.46 | 6.13 | 5.04 | - | - | - | - | - | - |
Calculated values
| YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
|---|---|---|---|---|---|
| Volatility | 16.37% | 16.28% | 16.52% | 20.69% | 23.37% |
| Sharpe ratio | 1.16 | 1.05 | 1.13 | 0.19 | 0.28 |
| Best month | +12.72% | +6.13% | +12.72% | +12.72% | +12.72% |
| Worst month | -5.29% | -5.29% | -5.57% | -9.93% | -9.93% |
| Maximum loss | -9.21% | -9.21% | -9.21% | -21.19% | -23.19% |
| Outperformance | -3.11% | - | -0.37% | - | - |
All quotes in GBP
Share classes
| Name | Type of yield | Repurchase p. | 1 Year | 3 Years | |
|---|---|---|---|---|---|
| Candriam Equities L Biotechnolog... | reinvestment | 2,286.9800 | +22.63% | +17.56% | |
| Candriam Equities L Biotech.C EU... | reinvestment | 243.7100 | +23.94% | +27.10% | |
| Candriam Equities L Biotech.I-H ... | reinvestment | 2,281.9399 | +20.02% | +9.12% | |
| Candriam Equities L Biotech.I EU... | reinvestment | 2,456.6499 | +24.63% | +27.49% | |
| Candriam Equities L Biotech.I GB... | reinvestment | 3,725.7200 | +22.30% | +24.47% | |
| Candriam Equities L Biotech.R GB... | reinvestment | 391.8100 | +22.77% | +28.77% | |
| Candriam Equities L Biotech.R EU... | reinvestment | 360.1900 | +25.10% | +30.50% | |
| Candriam Equities L Biotech.R-H ... | reinvestment | 221.7800 | +17.46% | +7.23% | |
| Candriam Equities L Biotech.V2 U... | reinvestment | 2,051.3999 | +23.27% | +20.87% | |
| Candriam Equities L Biotechnolog... | reinvestment | 165.2000 | - | - | |
| Candriam Equities L Biotech.N US... | reinvestment | 665.2100 | +21.44% | +15.58% | |
| Candriam Equities L Biotech.I US... | reinvestment | 6,255.2002 | +22.48% | +17.13% | |
| Candriam Equities L Biotech.C-H ... | reinvestment | 218.3800 | +19.44% | +8.94% | |
| Candriam Equities L Biotech.R US... | reinvestment | 297.2000 | +22.96% | +19.96% | |
| Candriam Equities L Biotech.R-H ... | reinvestment | 228.0600 | +20.44% | +11.65% | |
| Candriam Equities L Biotechnolo... | reinvestment | 934.3600 | +21.88% | +17.02% | |
| Candriam Equities L Biotechnolog... | paying dividend | 853.2800 | +21.84% | +16.91% |
Performance
| YTD | +12.18% | ||
|---|---|---|---|
| 6 Months | +9.87% | ||
| 1 Year | +22.30% | ||
| 3 Years | +24.47% | ||
| 5 Years | +62.78% | ||
| 10 Years | - | ||
| Since start | +148.38% | ||
| Year | |||
| 2023 | +1.50% | ||
| 2022 | +9.66% | ||
| 2021 | -1.63% | ||
| 2020 | +17.29% | ||
| 2019 | +28.66% | ||
| 2018 | -4.56% | ||
| 2017 | +16.06% | ||
